Fundamental dimension Equity attribute | EQBKPeer $48.88▲+0.49% Cap $1.01BP/E 10.6x QuantScore53/100 | BFSTLeader $31.80▼-0.44% Cap $1.04BP/E 11.3x QuantScore67/100 | CFFNPeer $8.40▲+0.84% Cap $1.04BP/E 12.9x QuantScore55/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
94/100 |
93/100 |
80/100 |
Valuation Multiples, PEG & DCF upside | 96/100 | 77/100 | 69/100 |
Health Piotroski, Altman Z, leverage & liquidity | 24/100 | 43/100 | 44/100 |
Growth Revenue / earnings growth & margins | 34/100 | 53/100 | 46/100 |
Sentiment Analyst ratings, targets & revisions | 16/100 | 68/100 | 34/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 10.6x | 11.3x | 12.9x |
Forward P/E (next FY) | 10.6x | 10.6x | 12.3x |
EV / EBITDA (TTM) | 7.3x | 16.4x | 23.1x |
Price / Sales | 2.2x | 2.3x | 2.4x |
Price / Free Cash Flow | 21.6x | 10.5x | 14.5x |
PEG ratio | 0.04 | 0.95 | 0.34 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 6 / 9 | 8 / 9 |
Altman Z-Score | -0.66 (Distress) | 0.25 (Distress) | 1.16 (Distress) |
Total debt / equity | 0.65 | 0.61 | 1.60 |
Quick ratio | 0.1x | 2.1x | 66.4x |
Interest coverage | 0.9x | 0.3x | 0.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -3.8% | +11.8% | +10.0% |
Net income growth YoY | -63.7% | +34.9% | +79.0% |
Gross margin (TTM) | 69.0% | 56.4% | 49.9% |
Operating margin (FY) | 10.4% | 22.2% | 19.9% |
FCF margin (FY) | 12.1% | 18.0% | 11.9% |
5. Trailing price performancePrice change over period |
1M return | +1.1% | +3.0% | -3.2% |
3M return | -2.8% | +2.1% | -2.9% |
6M return | +7.8% | +12.5% | +9.2% |
Year to date | +9.5% | +21.7% | +23.3% |
1Y return | +17.5% | +31.1% | +31.7% |
3Y return | +102.5% | +71.2% | +68.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $65.69 +34.4% upside | $22.59 -29.0% premium | $-5.20 -161.9% premium |
Wall Street consensus target | $54.20 +10.9% · range $50.00–$60.00 | $34.50 +8.5% · range $33.00–$36.00 | $9.75 +16.1% · range $9.50–$10.00 |
Consensus stance | 33% Buy67% Hold0% Sell | 100% Buy0% Hold0% Sell | 0% Buy100% Hold0% Sell |